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Abstract 
The superoxide-producing NADPH oxidase consists of membrane-associated cytochrome b,,, and cytosolic components, 
p47-phox and p67-phox. Recently, we have found a novel cytosolic component, p40-phox, which is tightly associated with 
p67-phox. In this study, we examined the translocation of p40-phox during activation of NADPH oxidase in a cell-free 
system using the membrane and the purified p47-phox/p67-phox/p40-phox complex. p40-phox was translocated to the 
membrane by arachidonic acid in a dose-dependent manner. The translocation pattern of p40-phox was similar to those of 
p47-phox and p67-phox. However, immunoprecipitation assay revealed that p40-phox was dissociated from p47-phox and 
p67-phox during activation. The translocation of three cytosolic components was not affected by the deletion of GTP-y-s 
from the reaction mixture. Interestingly, a synthetic peptide corresponding to carboxyl-terminus of p40-phox inhibited the 
activation of NADPH oxidase and translocation of p40-phox, p47-phox and p67-phox, suggesting that p40-phox might play 
a role in the activation of NADPH oxidase. These observations suggest that p40-phox is dissociated from p67-phox during 
activation, and translocates to the membrane by GTP-y-s-independent mechanism. 
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1. Introduction 
Neutrophils and other phagocytic cells exhibit a 
stimulus-dependent burst of oxidative metabolism 
which leads to the formation of superoxide anion and 
other toxic oxygen derivatives [l-4]. The respiratory 
burst is induced by the activation of superoxide-pro- 
ducing enzyme, NADPH oxidase, which is a multi- 
component electron-transfer complex. The compo- 
nents of the enzyme are distributed in both membrane 
and cytosol in resting state [5,6]. Cytochrome b,,, 
which is composed of two subunits gp91-phox and 
p22-phox, has been known as the membrane-bound 
component [7-91. p47-phox and p67-phox have been 
identified as the cytosolic components [ 10-131. In 
addition, the cytosolic small GTP-binding protein 
p2lrac has been known as a functional component of 
the oxidase [ 14-161. On cell activation, the cytosolic 
components translocate to the plasma membrane, 
where they associate with cytochrome b,,,, forming 
the active NADPH oxidase [13,17]. The membrane 
and cytosolic components are assumed to assemble 
each other via the protein-protein interaction between 
Abbreviations: SDS-PAGE, sodium dodecyl sulfate polyacryl- 
amide gel electrophoresis; Phox, phagocyte oxidase factor. 
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Src homology 3 (SH3) domains and the polyproline logical Laboratories (Japan). Other reagents were of 
motifs [ 18-221. analytical grade. 
It has been reported that p47-phox and p67-phox 
are present as a complex in resting neutrophils [23- 
251. We have purified the 260 kDa cytosolic complex 
from guinea pig neutrophils [23]. The complex is 
essential for the activation of NADPH oxidase, and is 
composed of p47-phox, p67-phox and a novel 39 kDa 
protein which is tightly associated with p67-phox. 
Recently, p40-phox which is associated with p67- 
phox, has been found in human neutrophils [26,27]. 
The homologies of amino acid sequences and the 
tight association with p67-phox indicate that the 
guinea pig 39 kDa protein and human p40-phox are 
homologues [3,4]. However, the role of p40-phox in 
the activation of NADPH oxidase is not clear. 
2.2. Preparation of neutrophil membrane and cytosol 
fractions 
In the present study, to clarify the role of p40-phox, 
we examined the translocation of p40-phox, and the 
effect of GTP-y-s and p40-phox-derived synthetic 
peptides on NADPH oxidase activity using guinea 
pig p40-phox (39kDa protein). 
2. Materials and methods 
2.1. Reagents 
Cytochrome c (Type VI), arachidonic acid (free 
acid), diisopropyl fluorophosphate (DFP), phenyl- 
methanesulfonyl fluoride (PMSF), superoxide dismu- 
tase (SOD), flavin adenine dinucleotide (FAD:dis- 
odium salt), glycogen (TypeII, from oyster), bovine 
serum albumin (fraction V) and keyhole limpet 
hemocyanin (KLH) were purchased from Sigma 
Chemical Co. (USA). Guanosine 5’-0-(3- 
thiotriphosphate) (GTP-7-s) was obtained from 
Boehringer Mannheim (Germany). Piperazine-N,N’- 
bis(2-ethanesulfonic acid) (PIPES) was obtained from 
Dojindo Laboratories (Japan). Ethylene glycol-bis- 
( /3-aminoethyl ether)-N, N, N’, N’-tetraacetic acid 
(EGTA) was obtained from Nacalai Tesque Inc. 
(Japan). P-nicotinamide adenine dinucleotide phos- 
phate, reduced form (NADPH), was obtained from 
Oriental Yeast Co., Ltd. (Japan). Trichloroacetic acid 
solution was obtained from Wako Pure Chemical 
Industries Ltd. (Japan). Pepstatin A and leupeptin 
were obtained from Peptide Institute, Inc. (Japan). 
Goat whole serum was obtained from Immuno-Bio- 
Guinea pig neutrophils were obtained from exu- 
dates 13-15 h after an intraperitoneal injection of 
0.17% glycogen in 0.9% saline [28]. The membrane 
and the cytosol fractions were prepared as previously 
described [23]. Briefly, neutrophils (2 X lOa cells/ml) 
were treated with 5 mM DFP in phosphate-buffered 
saline (PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 mM 
Na,HPO,, 1.5 mM KH,PO,, pH 7.4) for 30 min at 
4°C. After washing with PBS, neutrophils were sus- 
pended in 0.34 M sucrose buffer (13 1 mM NaCl, 8 
mM KH,PO,, 0.34 M sucrose containing 1 mM 
EGTA, 0.8 mM PMSF, 10 pg/ml pepstatin A and 
50 pug/ml leupeptin, pH 7.0) at 2 X 10’ cells/ml, 
and disrupted by sonication. The sonicates were cen- 
trifuged at 8500 X g for 15 min at 4°C to remove 
granule, nuclei and unbroken cells. The resulting 
supernatant was further centrifuged at 260000 X g 
for 1 h at 4°C. The obtained supernatant (the cytosol 
fraction) was used for the purification of the p47- 
phox/p67-phox/p40-phox complex. The pellet (the 
membrane fraction) was suspended in 0.34 M sucrose 
buffer, centrifuged at 260000 X g for 1 h, and resus- 
pended in 0.34 M sucrose buffer. The membrane and 
the cytosol fractions were stored at - 80°C until use. 
2.3. Purification of the p47-phox/p67-phox/p40- 
phox complex 
The p47-phox/p67-phox/p40-phox complex was 
purified from the cytosol fraction as described previ- 
ously [23]. The cytosol fraction (about 500 mg pro- 
tein) was filtered through a Sephadex G-25 column 
(Pharmacia LKB Biotechnology, Sweden) equili- 
brated with buffer A (20 mM sodium phosphate, pH 
7.0, containing 0.5 mM EGTA and 0.5 mM PMSF). 
The void fraction was applied to a S-Sepharose Fast- 
Flow column (Pharmacia LKB Biotechnology) equi- 
librated with buffer A, and proteins were eluted with 
a O-O.5 M NaCl gradient. Each fraction was moni- 
tored for activation of NADPH oxidase in a cell-free 
assay system using the membrane fraction and 
arachidonic acid [23]. The active fractions containing 
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the p47-phox/p67-phox/p40-phox complex identi- 
fied by Western blot analysis, were dialyzed against 
buffer B (10 mM sodium phosphate, pH 7.0), applied 
to a Biofine HAC-5CP hydroxyapatite column 
(JASCO-Japan Spectroscopic Co., Japan) equilibrated 
with buffer B, and eluted with a O-O.3 M sodium 
phosphate (pH 7.0). The active fractions containing 
the complex were mixed with 5 ~01s. of buffer A, 
applied to a Cosmogel CM column (Nacalai Tesque 
Inc.) equilibrated with Buffer A, and eluted with a 
O-O.5 M NaCl gradient. The purified complex was 
essentially free of contaminating proteins by SDS- 
PAGE analysis with silver staining, and was stored at 
- 80°C until use. 
2.4. Chemical synthesis of peptides 
The peptides, DIAVEEDLSSTPP (peptide 1) and 
HITQQDNYSVYNTTPSATQ (peptide 2), which had 
been identified by the amino acid sequence analysis 
of p40-phox [23], and TNISQYHTQTAPVSQDTNY 
(peptide 3; the scrambled form of peptide 2) were 
synthesized on a model 430A peptide synthesizer 
(Perkin Elmer Applied Biosystems Division, USA) 
according to the F-mot method [29]. The peptides 
were released from the solid-phase resin with triflu- 
oroacetic acid containing 1 M trifluormethane- 
sulfonic acid and 5% 1,2_ethanedithiol. The crude 
peptides were purified by reverse phase high perfor- 
mance liquid chromatography. Synthetic peptides 
were stored as lyophilized powders at - 80°C. 
2.5. Preparation of antiserum and affinity purifica- 
tion of antibody 
Antiserum was raised in rabbits using the synthetic 
peptide 1 covalently coupled to KLH by the method 
of Liu et al. [30]. The 200 pg of KLH-conjugated 
peptide was homogenized in Freund’s complete adju- 
vant and injected subcutaneously into rabbits, fol- 
lowed by 4 boosts (every week) of conjugated pep- 
tide (100 pg) in Freund’s incomplete adjuvant. 
Antibody was purified by affinity chromatography. 
Peptide-conjugated beads were prepared by coupling 
of peptide to Epoxy-activated Sepharose 6B (Phar- 
macia LKB Biotechnology) as described by the man- 
ufacturer. After washing with water, the beads were 
resuspended in TBS (20 mM Tris-HCl, pH 7.5, con- 
taining 0.15 M NaCl). Antiserum was applied to the 
peptide-conjugated beads equilibrated with TBS, and 
stood for 15 min at 4°C. After sequentially washing 
with TBS supplemented with 0.5% Triton X-100 and 
0.15 M NaCl, the bound IgG was eluted using 0.1 M 
glycine-HCl (pH 2.5). IgG solution was neutralized 
with the addition of l/20 volumes of 1 M Tris, and 
was stored at - 80°C until use. Purified antibody was 
used in immunoprecipitation experiment as described 
below. 
2.6. Assay for translocation of cytosolic components 
and NADPH oxidase activity in a cell-free system 
The mixtures containing 60 pg of membrane, 120 
ng of the cytosolic p47-phox/p67-phox/p40-phox 
complex, 10 PM GTP-y-s and 5 mM MgCl, were 
preincubated at 25°C for 5 min, and then added with 
various concentration of arachidonic acid in a total 
volume of 0.4 ml relaxation buffer (100 mM KCl, 3 
mM NaCl, 3.5 mM MgCl, 1.25 mM EGTA, 10 mM 
PIPES, pH 7.4). After activation with arachidonic 
acid for 5 min at 25°C the mixtures (0.4 ml) were 
layered onto a discontinuous sucrose gradient com- 
posed of 0.4 ml of 15% (w/v) sucrose over 0.2 ml of 
50% (w/v> sucrose in relaxation buffer, and cen- 
trifuged at 105 000 X g for 30 min at 20°C. After 
centrifugation, 0.6-ml fractions were withdrawn from 
the top, and used as the ‘supernatant’. Residual frac- 
tions (0.4 ml) containing the interface of the 15/50% 
sucrose layers were collected and used as the ‘mem- 
brane’. The ‘supernatant’ was treated with ice-cold 
trichloroacetic acid ( 10%) for 15 min on ice, and 
centrifuged (12000 X g, 10 min). The protein pellets 
were resuspended in SDS-PAGE sample buffer. The 
‘membrane’ was diluted in relaxation buffer, cen- 
trifuged (200000 X g, 1 h), and resuspended in relax- 
ation buffer. The membrane and the supernatant were 
subjected to SDS-PAGE/Western blotting. 
When the membrane was omitted from the activa- 
tion mixture, p40-phox, p47-phox and p67-phox were 
not recovered from the interface of the 15/50% 
sucrose layers. Therefore, arachidonic acid is unlikely 
to cause the formation of large protein complexes of 
cytosolic components in our system (data not shown). 
NADPH oxidase activity of the membrane was 
measured by a spectrophotometric assay of cy- 
tochrome c reduction 123,281. The assay mixtures 
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consisted of 10 pg of activated membrane (as de- 
scribed above), 80 ,uM cytochrome c, 10 PM FAD, 
and 200 ,uM NADPH in the total volume of 0.5 ml 
relaxation buffer, and the assay was performed at 
37°C in a Hitachi 557 dual-wavelength spectro- 
photometer (Hitachi, Ltd., Japan). Cytochrome c re- 
duction was calculated from the linear portion of the 
increase in the absorbance difference at 550-540 nm 
by using an absorption coefficient of 21000 M- ’ 
cm- ‘. 
2.7. Immunoprecipitation 
The cytosolic p47-phox/p67-phox/p40-phox 
complex (200 ng) was incubated with or without 100 
FM arachidonic acid for 5 min at 20°C in the total 
volume of 0.4 ml relaxation buffer, and then 
affinity-purified anti-p40-phox rabbit polyclonal anti- 
body (10 pg) was added. After incubation for 2 h at 
4°C protein G Sepharose beads (10 ~1; Pharmacia 
LKB Biotechnology) were added, and rotated for 1.5 
h at 4°C. The beads were washed four times by 
relaxation buffer, and suspended in SDS-PAGE sam- 
ple buffer. The cytosolic components were subjected 
to SDS-PAGE/Western blotting. 
2.8. Esfects of synthetic peptides on translocation of 
cytosolic components and NADPH oxidase activity 
The mixtures containing 60 pg of membrane, 120 
ng of the cytosolic p47-phox/p67-phox/p40-phox 
complex, 10 PM GTP- y-s and 5 mM MgCl, were 
preincubated with various concentrations of the syn- 
thetic peptides at 25°C for 5 min, and then added 
with 100 ,uM arachidonic acid in a total volume of 
0.4 ml relaxation buffer. After 5 min at 25’C, the 
membrane was isolated by sucrose gradient centrifu- 
gation. As described in Section 2.6, the membrane 
was subjected to SDS-PAGE/Western blotting for 
evaluation of translocation of cytosolic components, 
and NADPH oxidase activity was measured by spec- 
trophotometric assay. 
2.9. SDS-PAGE and Western blotting 
The membrane and the supernatant prepared in the 
above sections were subjected to SDS-PAGE on 13% 
polyacrylamide gels based on the method of Laemmli 
and Faver [31]. The resolved proteins were elec- 
trophoretically transferred to nitrocellulose filters. The 
blots were blocked in Block Ace (Dainippon Pharma- 
ceutical Co. Ltd., Japan) containing 10 mg/ml BSA. 
Then, the blots were incubated 15 h at 4°C with the 
anti-p47-phox and anti-p67-phox mouse monoclonal 
antibodies (diluted 5000-fold in 10% Block Ace), or 
anti-p40-phox rabbit polyclonal antibody (diluted 
lOOO-fold in 10% Block Ace containing 1% goat 
A Membrane supernatant 
Arachidonicpctd (r M) o 5 ,5 50 100 150 250 0 250 
p67-phox - w 
,,I,, 
p47-phox - JJ+ 
p40-phox - -w 
B 100 c P 
0 5 15 50 100 150 250 
Arachidonic acid (Y M) 
- 
0 5 15 50 100 150 250 
Arachidomc acid (II M) 
Fig. 1. Dose-dependency of arachidonic acid on translocation of 
cytosolic components and NADPH oxidase activity. The mixtures 
containing the membrane and the cytosolic p47-phox/p67- 
phox/p40-phox complex were stimulated by various concentra- 
tions of arachidonic acid. After 5 mitt, the membrane and the 
supematant were isolated from each mixture by sucrose gradient 
centrifugation. (A) The membrane and the supematant were 
analyzed by SDS-PAGE/Western blotting. (B) The translocated 
p40-phox (a), p47-phox (0) and p67-phox (A) to the mem- 
brane were quantified by scanning. Translocation is expressed as 
relative % compared with the amounts of cytosolic components 
stimulated by 250 /.LM arachidonic acid. (C) NADPH oxidase 
activities of the membrane. The results shown are the mean + SE. 
of six separate experiments. 
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Arachidonic acid - 
p67-phox - 
p47-phox - 
p67-phox - 
p47-phox - 
- p40-phox - p40-phox 
Fig. 2. Immunoprecipitation analysis using anti-p40-phox peptide antibody. p47-phox/p67-phox/p40-phox complex was incubated 
without (-1 or with (+> arachidonic acid, then immunoprecipitation was performed using anti-p40-phox antibody. The 45-65 kDa 
intense bands were the heavy chains of rabbit IgG contained in anti-p40-phox rabbit antibody. The results are representative of five 
separate experiments. 
whole serum). The cytosolic components were de- 
tected using horseradish peroxidase-conjugated goat 
anti-mouse IgG/IgM (5000-fold diluted; Kirnegaad 
and Petty, USA) or goat anti-rabbit IgG (lOOOO-fold 
diluted; Organon Teknika Co., USA) with ECL 
Western blotting system (Amersham International plc, 
UK). We confirmed that anti-p40-phox, anti-p47-phox 
and anti-p67-phox antibodies specifically reacted with 
p40-phox, p47-phox and p67-phox, respectively. To 
measure the relative amounts of the translocated cy- 
tosolic components to the membrane, the bands de- 
tected by ECL were scanned using MasterScanTY 
System (Scanalytics, USA). 
In this study, p40-phox band detected was doublet. 
Analysis of partial amino acid sequences of these two 
proteins revealed that the sequences of the two pro- 
teins were identical (data not shown). Therefore, the 
low molecular weight protein reacting with anti-p40- 
phox antibody is likely a partially degraded protein of 
p40-phox. 
3. Results 
3.1. Tramlocation of p40-phox to the membrane 
To elucidate the role of p40-phox in activation of 
NADPH oxidase, we first examined the translocation 
of p40-phox to the membrane by stimulation with 
various concentrations of arachidonic acid using the 
cytosolic p47-phox/p67-phox/p40-phox complex. 
As shown in Fig. lA,B, p40-phox, p47-phox and 
p67-phox were translocated to membrane, dependent 
on the concentrations of arachidonic acid. The 
translocation pattern of p40-phox was similar to those 
of p47-phox and p67-phox. Fig. 1C shows a dose-de- 
pendency of NADPH oxidase activity on arachidonic 
acid. NADPH oxidase activity was maximally acti- 
vated by loo-150 PM arachidonic acid, whereas the 
oxidase was little activated below 50 PM arachidonic 
acid. 
c 
L 
Arachidonic acid - 
GTP-y-s + 
+ 
+ 
+ 
p67-phox - 
p47-phox - 
p40-phox - < 
Fig. 3. Effect of GTP-y-s on NADPH oxidase activity and 
translocation of cytosolic components. The mixtures containing 
the membrane and the cytosolic p47-phox/p67-phox/p4O-phox 
complex were incubated with (+I or without (--) arachidonic 
acid (100 PM) in the presence c-t-1 or absence (-) of 10 PM 
GTP-y-s. After 5 min, the membrane was isolated from each 
mixture by sucrose gradient centrifugation. Upper: NADPH oxi- 
dase activity of the membrane. Lower: SDS-PAGE/Western 
blotting of the membrane. The results are representative of three 
separate experiments. 
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Next, to examine whether p40-phox is dissociated 
from p47-phox and p67-phox during activation, we 
performed the immunoprecipitation using p40-phox 
antibody. As shown in Fig. 2, p47-phox and p67-phox 
were recovered in the p40-phox/anti-p40-phox anti- 
body complex without arachidonic acid-treatment (in 
resting state). In contrast, p47-phox and p67-phox 
were lost from the complex by arachidonic acid-treat- 
ment. Although we previously observed that p40-phox 
was tightly associated with p67-phox in resting state 
[23], the results of immunoprecipitation analysis sug- 
gest that p40-phox is dissociated from p67-phox dur- 
ing activation. 
3.2. Effect of GTP-y-s on NADPH oxidase activity 
and translocation of cytosolic components 
We examined the effect of GTP-y-s on NADPH 
oxidase activity and translocation of p40-phox, p47- 
phox and p67-phox. As shown in Fig. 3, activation of 
NADPH oxidase by arachidonic acid was dependent 
on GTP-y-s. On the other hand, translocation of 
1 10 
Peptide concentrat,~” ( L( M) 
Fig. 4. Effects of p40-phox-derived peptides on NADPH oxidase 
activity. The mixtures containing the membrane and the cytosolic 
p47-phox/p67-phox/p40-phox complex were preincubated for 5 
min with the indicated concentrations of peptide 1 (O), peptide 2 
(0) or peptide 3 (A ). Then, the mixtures were added with 
arachidonic acid. After 5 min, the membrane fractions were 
isolated from each mixture by sucrose gradient centrifugation. 
Then, NADPH oxidase activity of membrane fractions were 
measured. NADPH oxidase activity stimulated in the absence of 
peptides was 325.5 f 47.3 nmol/min/mg membrane protein 
(mean + S.E.). The results shown are the mean+ SE. of three 
separate experiments. 
Peptide 2 Peptide 1 
0.1 1 10 30 100 
Peptide concentration (u M) 
LIP 
0.1 1 10 30 100 
Peptide concentration (!.I M) 
Fig. 5. Effects of p40-phox-derived peptides on translocation of 
cytosolic components. The mixtures containing the membrane 
and the cytosolic p47-phox/p67-phox/p40-phox complex were 
preincubated for 5 min with the indicated concentrations of 
peptide 2 (A) or peptide 3 (B). Then, the mixtures were added 
with arachidonic acid. After 5 min, the membrane fractions were 
isolated from each mixture by sucrose gradient centrifugation. 
Translocation of the cytosolic components to the membrane was 
analyzed by SDS-PAGE/Western blotting. The translocated 
p40-phox (01, p47-phox (0) and p67-phox ( A ) is expressed as 
relative % of the amounts of cytosolic components stimulated in 
the absence of the peptide. The results shown are the mean f S.E. 
of 3-6 separate experiments. Inset: Western blotting of the 
translocated cytosolic components to the membrane in the pres- 
ence of peptide 1 (100 PM) or peptide 2 (30 PM). 
p40-phox, p47-phox and p67-phox to the membrane 
by arachidonic acid was independent of GTP-y-s. 
3.3. Efsects of synthetic peptides on NADPH oxidase 
activity and translocation of cytosolic components 
We previously identified the amino acid sequences 
of the two fragments (DIAVEEDLSSTPPF and 
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LHITQQDNYSVYNTTPSATQ) of guinea pig p40- 
phox [23] corresponding to the sequences of the 
residues 252-265 and the residues 325-349 
(carboxyl-terminal sequence) of human p40-phox, re- 
spectively [26]. Then, we examined the effect of 
these synthetic peptides DIAVEEDLSSTPP (peptide 
1) and HITQQDNYSVYNTTPSATQ (peptide 21 on 
NADPH oxidase activity. Peptide 1 had no effect on 
NADPH oxidase activity (Fig. 4). On the other hand, 
peptide 2 inhibited NADPH oxidase activity in a 
concentration-dependent manner (IC,, of 3-4 PM). 
The activity was reduced to about 30% of control by 
50 PM peptide 2. When peptide 2 was added 5 min 
after arachidonic acid stimulation, no inhibitory effect 
was observed (data not shown). These results indicate 
that peptide 2 acts on the activation process of 
NADPH oxidase but not on the activated oxidase. 
Peptide 3 (TNISQYHTQTAPVSQDTNY) with the 
same amino acid composition as peptide 2 but with a 
scrambled sequence had no effect on the NADPH 
oxidase activity. 
Furthermore, the effects of these peptides on 
translocation of cytosolic components to the mem- 
brane were examined. As shown in Fig. 5A, translo- 
cation of p40-phox, p47-phox and p67-phox was 
dose-dependently inhibited by peptide 2. IC,, values 
for three cytosolic components were l-2 ,uM. On 
the other hand, peptides 1 and 3 did not inhibit the 
translocation of cytosolic components (Fig. 5A, inset 
and Fig. 5B). 
4. Discussion 
We have recently identified a new 39 kDa cytoso- 
lit component, which is complexed with p67-phox 
and p47-phox, in guinea pig neutrophils [23]. Other 
investigators have also identified a new cytosolic 
component, p40-phox, in human neutrophils [26,27]. 
Homologies of amino acid sequences between 39 
kDa protein (DIAVEEDLSSTPP and HITQQD- 
NYSVYNTTPSATQ) and p40-phox (residues 252- 
265 and 325-349) are more than 85% [23,27], sug- 
gesting that guinea pig 39 kDa cytosolic component 
is a homologue of p40-phox [3,4]. p40-phox is as- 
sumed to play a role in stabilizing p67-phox [32], 
because p40-phox is tightly associated with p67-phox 
and is markedly reduced in chronic granulomatous 
disease deficient in p67-phox [26,27]. However, the 
role of the p40-phox in the activation of NADPH 
oxidase is not clear. 
In this study, using guinea pig p40-phox, we have 
observed that p40-phox is translocated to the mem- 
brane by arachidonic acid in a dose-dependent man- 
ner. The translocation pattern of p40-phox was simi- 
lar to those of p47-phox and p67-phox. Previously, 
we found that p40-phox was tightly associated with 
p67-phox in resting state. However, the immuno- 
precipitation experiment revealed that p40-phox was 
dissociated from p47-phox and p67-phox by arachi- 
donic acid stimulation. 
Translocation of p40-phox, p47-phox and p67-phox 
was not affected by the deletion of GTP-y-s from the 
reaction mixture, suggesting these cytosolic compo- 
nents translocate independent of G-protein. On the 
other hand, the activation of NADPH oxidase was 
dependent on the GTP-y-s. p2lrac, one of the small 
G-proteins, have been known as a functional compo- 
nent of the oxidase [14-161. A small amount of 
p2lrac is associated with the membrane, and the rest 
of p2lrac is present in the cytosol [33]. In this study, 
we did not add the p2lrac to the activation mixture, 
but substantial activity of NADPH oxidase was ob- 
tained. We detected that a small amount of p2lrac 
was associated with the resting and activated mem- 
brane by Western blot analysis (data not shown). 
Therefore, p2lrac associated with the membrane may 
be enough for the activation of NADPH oxidase, as 
reported in the previous paper [33]. Recently, the 
membrane-bound small G-protein rap1 is reported to 
be involved in the regulation of NADPH oxidase 
[3,4,34]. However, a role of rap1 in the activation of 
NADPH oxidase is controversial [3]. 
Addition of synthetic peptide 2, corresponding to 
the carboxyl-terminus of p40-phox, inhibited the acti- 
vation of NADPH oxidase. Furthermore, peptide 2 
inhibited the translocation of p40-phox, p47-phox and 
p67-phox. On the other hand, peptide 1 and peptide 3 
(with the same amino acid composition as peptide 2 
but with a scrambled sequence) inhibited neither 
NADPH oxidase activity nor translocation of cytoso- 
lit components. Therefore, the inhibitory effects of 
peptide 2 seems to be sequence-specific. 
Recently, Fuchs et al. [35] have suggested that 
p40-phox likely functions as a chaperone for p67-phox 
via the interaction between the carboxyl-terminus of 
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p40-phox and p67-phox. After stimulation, p47-phox 
is known to associate first with p22-phox, subunit of 
cytochrome b,,, , followed by the binding with p67- 
phox [12,13,18,22]. Interestingly, Uhlinger et al. [36] 
have revealed that p67-phox enhances the binding of 
p47-phox to the membrane. These observations sug- 
gest that peptide 2 (corresponding to the carboxyl- 
terminus of p40-phox) might reduce the translocation 
of p47-phox and p67-phox by affecting the function 
of p67-phox through the competition with p40-phox 
for the binding to p67-phox. However, the possibility 
that peptide 2 might affect the interaction between 
p22-phox and p47-phox, and/or p47-phox and p67- 
phox, cannot be excluded. The detailed mechanism of 
the action of peptide 2 remains to be clarified. 
In summary, we found that p40-phox was dissoci- 
ated from p67-phox and p47-phox during activation, 
and translocated to the membrane independent of 
GTP-y-s. Furthermore, we observed that the car- 
boxyl-terminal peptide of p40-phox inhibited the acti- 
vation of NADPH oxidase and translocation of cy- 
tosolic components, suggesting that p40-phox might 
be involved in the activation of NADPH oxidase. 
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